These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36622496)

  • 1. Neonatal immunization prevents the development of a chronic autoimmune response against CD4 caused by HIV-1 gp120 in rats.
    Beduleva L; Khramova T; Menshikov I; Frolov M; Gilmanova L
    Immunol Res; 2023 Jun; 71(3):463-474. PubMed ID: 36622496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Action of Anti-CD4 Autoantibodies and Rheumatoid Factor in the Development of CD4 Lymphocytopenia in Rats Immunized with HIV-1 gp120.
    Beduleva L; Khramova T; Menshikov I; Stolyarova E; Pavlova S
    AIDS Res Hum Retroviruses; 2016 Dec; 32(12):1173-1179. PubMed ID: 26916783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
    Neurath AR; Strick N; Li YY; Jiang S
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-covalent complexes of HIV gp120 with CD4 and/or mAbs enhance activation of gp120-specific T clones and provide intermolecular help for anti-CD4 antibody production.
    Manca F; Seravalli E; Valle MT; Fenoglio D; Kunkl A; Li Pira G; Zolla-Pazner S; Celada F
    Int Immunol; 1993 Sep; 5(9):1109-17. PubMed ID: 7902128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection.
    Burastero SE; Figini M; Frigerio B; Lusso P; Mollica L; Lopalco L
    J Transl Med; 2009 Nov; 7():101. PubMed ID: 19943950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
    Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
    J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ongoing immune response to HIV envelope gp120 in human CD4-transgenic mice contributes to T cell decline upon intravenous administration of gp120.
    Kang Y; Melo EF; Scott DW
    Eur J Immunol; 1998 Aug; 28(8):2253-64. PubMed ID: 9710203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type 1 glycoprotein 120-specific T lymphocytes provide intermolecular help for anti-CD4 autoantibody production in exposed uninfected subjects.
    Furci L; Beretta A; Siccardi A; Lazzarin A; Confetti C; Magnani Z; Scarpellini P; Lopalco L; Burastero SE
    AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1461-9. PubMed ID: 9390745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A response to P.H. Duesberg with reference to an idiotypic network model of AIDS immunopathogenesis.
    Hoffmann GW
    Res Immunol; 1990 Oct; 141(8):701-9. PubMed ID: 2089529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes.
    Liegler TJ; Stites DP
    J Acquir Immune Defic Syndr (1988); 1994 Apr; 7(4):340-8. PubMed ID: 7907660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell vaccination against anti-CD4 autoimmunity in HIV-1 infected patients.
    Abulafia-Lapid R; Bentwich Z; Keren-Zur Y; Cohen IR; Atlan H
    J Clin Virol; 2004 Dec; 31 Suppl 1():S48-54. PubMed ID: 15567094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 modulation of noninfected human T lymphocytes by HIV-1 envelope glycoprotein gp120: contribution to the immunosuppression seen in HIV-1 infection by induction of CD4 and CD3 unresponsiveness.
    Theodore AC; Kornfeld H; Wallace RP; Cruikshank WW
    J Acquir Immune Defic Syndr (1988); 1994 Sep; 7(9):899-907. PubMed ID: 7914230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques.
    Schwartz JA; Prado I; Misamore J; Weiss D; Francis J; Pal R; Huaman M; Cristillo A; Lewis GK; Gallo RC; DeVico AL; Fouts TR
    Clin Vaccine Immunol; 2016 Jul; 23(7):618-27. PubMed ID: 27193040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential occurrence of IgM, IgM/IgG, and gp120-IgM/IgG complement complexes on CD4+ lymphocytes in relation to CD4+ blood lymphocyte depletion in HIV+ hemophilia patients: results of a 10-year study.
    Daniel V; Süsal C; Weimer R; Zipperle S; Kröpelin M; Zimmermann R; Huth-Kühne A; Opelz G
    Immunol Lett; 1995; 47(1-2):97-102. PubMed ID: 8537109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals.
    Lichterfeld M; Gandhi RT; Simmons RP; Flynn T; Sbrolla A; Yu XG; Basgoz N; Mui S; Williams K; Streeck H; Burgett-Yandow N; Roy G; Janssens M; Pedneault L; Vandepapelière P; Koutsoukos M; Demoitié MA; Bourguignon P; McNally L; Voss G; Altfeld M
    J Acquir Immune Defic Syndr; 2012 Jan; 59(1):1-9. PubMed ID: 21963936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of T cell dysfunction with the presence of IgG autoantibodies on CD4+ lymphocytes in haemophilia patients; results of a 10-year study.
    Daniel V; Süsal C; Weimer R; Zipperle S; Kröpelin M; Zimmermann R; Huth-Kühne A; Opelz G
    Clin Exp Immunol; 1996 Apr; 104(1):4-10. PubMed ID: 8603531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-idiotypic antibodies to human anti-gp120 antibodies bind recombinant and cellular human CD4.
    Corre JP; Février M; Chamaret S; Thèze J; Zouali M
    Eur J Immunol; 1991 Mar; 21(3):743-51. PubMed ID: 1672646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity.
    Ghanem MH; Bolivar-Wagers S; Dey B; Hajduczki A; Vargas-Inchaustegui DA; Danielson DT; Bundoc V; Liu L; Berger EA
    Cytotherapy; 2018 Mar; 20(3):407-419. PubMed ID: 29306566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of CD4(+) cell counts from viral load and association with immune complexes in HIV(+) hemophilia patients.
    Sadeghi M; Daniel V; Naujokat C; Süsal C; Weimer R; Huth-Kühne A; Zimmermann R; Opelz G
    Immunol Lett; 2004 Jan; 91(1):23-32. PubMed ID: 14757366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.